期刊文献+

高通血液透析与血液透析滤过对改善尿毒症患者不宁腿和高血压的效果 被引量:2

Effects of High Permeability Hemodialysis and Hemodialysis Filtration on the Improvement of Unstable Leg Syndrome and Hypertension in Uremia Patients
下载PDF
导出
摘要 目的:比较高通量血液透析和血液透析滤过联合常规低通透析对改善不宁腿综合征和高血压的效果。方法:选取患者40人随机分成两组,每组20人,HFHD组高通量血液透析,HDF组血液透析滤过联合低通血液透析治疗,治疗6个月,比较两组患者治疗前后中分子毒素β2-微球蛋白的水平,血压情况和不宁腿有效率。结果:两组患者治疗前后β2-微球蛋白水平,血压水平均下降,有统计学差异,治疗后两组β2-微球蛋白,无统计学差异,HFHD组患者血压下降率,不宁腿综合征有效率优于HDF组,且有统计学差异。结论:两组患者治疗后β2-微球蛋白下降率无明显差异,但HFHD组患者血压下降的有效率,改善不宁腿综合征有效率优于HDF组。 Objective:To compare the effects of high Permeability hemodialysis and hemodialysis filtration combined with conventional low-pass dialysis on the improvement of Unstable Leg syndrome and hypertension.Methods:Select40 patients and randomly divide them into two groups of20 people.High-throughput hemodialysis in HFHD group,hemodialysis filtration in HDF group combined with low-pass hemodialysis,treatment for 6 months.To compare the efficiency of molecular toxin β2-microglobulin,blood pressure and unstable leg syndrome in two groups.Results:Theβ2 -microglobulin levels and blood pressure levels of the two groups of patients were reduced before and after treatment,which was statistically significant.After the treatment,there was no statistical difference between the two groups of β2- microglobulin.Blood pressure drop rate in HFHD group,unstable leg syndrome is more efficient than HDF group,and there's a statistical difference.Conclusion:There was no significant difference in the rate of decrease of β2-microglobulin after treatment between the two groups,but the rate of blood pressure decreasing and unstable leg syndrome in HFHD group was more effective than that of HDF group.
作者 罗倩 付慧 邓湾湾 LUO Qian;FU Hui;DENG Wan-wan(Medical Department of Yichun Second People's Hospital,Yichun336000,China)
出处 《宜春学院学报》 2019年第3期76-77,80,共3页 Journal of Yichun University
关键词 血液透析滤过 高通量透析 高血压 不宁腿 hemodialysis filtration high throughputdialysis hypertension unstable Leg
  • 相关文献

二级参考文献29

  • 1杨秀芹,孙玉兰.血液透析加血液灌流治疗尿毒症顽固性高血压[J].中国血液净化,2004,3(8):462-462. 被引量:77
  • 2彭小梅,龚智峰,闭闵,伍秋霞,张文欣,吴潮清.血液透析-灌流串联治疗尿毒症血透患者顽固性高血压的观察[J].广西医学,2006,28(2):194-196. 被引量:26
  • 3Mogi M, Harada M, Kojima K, et al. Selective removal of beta 2-mi- croglobulin from plasma specimens of long-term hemodialysis pa- tients by high-performance immunoaffinity chromatography[J]. Clin Chem, 1993, 39:277-280.
  • 4Yamamoto Y, Hirawa N, Yamaguchi S, et al. Long-term efficacy and safety of the small-sized beta2-microglobulin adsorption col- umn for dialysis-related amyloidosis[J]. Ther Apher Dial, 2011, 15: 466-474.
  • 5Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006, 17:546-555.
  • 6Liabeuf S, Lenglet A, Desjardins L, et al. Plasma beta-2 microglob- ulin is associated with cardiovascular disease in uremic patients[J]. Kidney Int, 2012, 82:1297-1303.
  • 7Kuragano T, Kida A, Furuta M, et al. The impact of beta2-micro- globulin clearance on the risk factors of cardiovascular disease in hemodialysis patients[J]. ASAIO J, 2010, 56:326-332.
  • 8Okuno S, Ishimura E, Kohno K, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodi- alysis patients[J]. Nephrol Dial Transplant, 2009, 24:571-577.
  • 9Loruoy W, Becaus I, Billiouw JM, et al. On-line haemodiafihration. Remarkable removal of beta2-microglobulin. Long-term clinical observations[J]. Nephrol Dial Transplant, 2000, 15 Suppl 1:49-54.
  • 10Vincent C, Revillard JP, Galland M, et al. Serum beta2-microglobu- lin in hemodialyzed patients[J]. Nephron, 1978, 21:260-268.

共引文献42

同被引文献21

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部